Eiger BioPharmaceuticals, Inc.
| Eiger BioPharmaceuticals, Inc. |
| United States Trustee |
| 8:2024bk80040 |
| April 1, 2024 |
| U.S. Bankruptcy Court for the Northern District of Texas |
| Other |
Docket Report
RSS Track this Docket
This docket was last retrieved on April 1, 2024. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 25 Declaration re: Declaration of David Apelian in Support of the Debtors Motion for Entry of an Order (I)(A) Approving the Bid Procedures; (B) Authorizing the Debtors to Select Sentynl Therapeutics, Inc. as the Zokinvy Stalking Horse Purchaser & Approving Bid Protections; (C) Approving the Bid Protections Relating to the Remaining Assets Stalking Horse Purchaser(S), if any; (D) Establishing Bid Deadlines, Auction(s), and Sale Hearing(s); (E) Approving the Form and Manner of Sale Notice; (F) Approving Assignment and Assumption Procedures; (G) Approving the Form and Manner of Potential Assumption and Assignment Notice; (II)(A) Authorizing the Sale of the Assets Free and Clear; and (B) Approving the Assumption and Assignment of Designated Contracts; and (III) Granting Related Relief filed by Debtor Eiger BioPharmaceuticals, Inc. (RE: related document(s)#13 Motion to establish procedures bid procedures. Debtors Motion for Entry of an Order (I)(A) Approving the Bid Procedures; (B) Authorizing the Debtors to Select Sentynl Therapeutics, Inc. as the Zokinvy Stalking Horse Purchaser & Approving Bid Protect). (Califano, Thomas) |
| Filing 24 Declaration re: Declaration of J. Scott Victor in Support of Debtors Motion for Entry of an Order (I)(A) Approving the Bid Procedures; (B) Authorizing the Debtors to Select Sentynl Therapeutics, Inc. as the Zokinvy Stalking Horse Purchaser & Approving Bid Protections; (C) Approving the Bid Protections Relating to the Remaining Assets Stalking Horse Purchaser(s), if any; (D) Establishing Bid Deadlines, Auction(s), and Sale Hearing(s); (E) Approving the Form and Manner of Sale Notice; (F) Approving Assignment and Assumption Procedures; (G) Approving the Form and Manner of Potential Assumption and Assignment Notice;(II)(A) Authorizing the Sale of the Assets Free and Clear; and (B) Approving the Assumption and Assignment of Designated Contracts; and (III) Granting Related Relief filed by Debtor Eiger BioPharmaceuticals, Inc. (RE: related document(s)#13 Motion to establish procedures bid procedures. Debtors Motion for Entry of an Order (I)(A) Approving the Bid Procedures; (B) Authorizing the Debtors to Select Sentynl Therapeutics, Inc. as the Zokinvy Stalking Horse Purchaser & Approving Bid Protect). (Califano, Thomas) |
| Filing 23 Agenda for Hearing scheduled on 4/3/2024 Agenda for Hearing Scheduled for April 3, 2024 at 1:30 p.m. (Prevailing Central Time) filed by Debtor Eiger BioPharmaceuticals, Inc. (RE: related document(s)#3 Motion for joint administration of cases 24-80040 (SGJ); 24-80041 (SGJ); 24-80042 (SGJ); 24-80043 (SGJ); 24-80044 (SGJ) Debtors Emergency Motion for Entry of an Order Directing Joint Administration of Chapter 11 Cases Filed by Debtor Eiger BioPharmaceuticals, Inc. (Attachments: # 1 Exhibit A), #4 Motion to maintain bank accounts. Debtors Emergency Motion for Entry of Interim and Final Orders (I) Authorizing the Debtors to Continue to Operate Their Cash Management System and Maintain Existing Bank Accounts (II) Honor Certain Obligations Relating Thereto; and (III) Granting a Waiver of Certain Deposit and Investment Requirements in 11 U.S.C. 345(B) and the USTGuidelines Filed by Debtor Eiger BioPharmaceuticals, Inc. (Attachments: # 1 Exhibit A # 2 Exhibit B # 3 Exhibit C # 4 Exhibit D), #5 Motion regarding utilities. Debtors Emergency Motion for Entry of an Order (I) Approving the Debtors Proposed Adequate Assurance of Payment for Future Utility Services, (II) Prohibiting Utility Companies from Altering, Refusing, or Discontinuing Services, and (III) Approving the Debtors Proposed Procedures for Resolving Additional Assurance Requests Filed by Debtor Eiger BioPharmaceuticals, Inc. (Attachments: # 1 Exhibit A # 2 Exhibit B), #6 Motion regarding pre or post petition contracts. Debtors Emergency Motion for Entry of an Order (I) Authorizing the Debtors to (A) Continue Their Prepetition Insurance Coverage and Satisfy Prepetition Obligations Related Thereto and (B) Renew, Supplement, and Enter Into New Insurance Policies, and (II) Granting Related Relief Filed by Debtor Eiger BioPharmaceuticals, Inc. (Attachments: # 1 Exhibit A # 2 Exhibit B), #7 Motion to extend time to Debtors Emergency Motion for Entry of an Order Extending Time to File Schedules of Assets and Liabilities and Statements of Financial Affairs Filed by Debtor Eiger BioPharmaceuticals, Inc. Objections due by 4/3/2024. (Attachments: # 1 Exhibit A), #8 Motion regarding pre or post petition contracts employee wages/benefits. Debtors Emergency Motion for Entry of an Order (I) Authorizing the Debtors to (A) Pay Prepetition Wages, Salaries, and Employee Benefits and (B) Continue the Postpetition Maintenance of Employee Benefit Programs, Policies, and Procedures in the Ordinary Course Filed by Debtor Eiger BioPharmaceuticals, Inc. (Attachments: # 1 Exhibit A), #9 Motion for approval of form notice. Debtors Emergency Motion For Entry of an Order Approving Notification and Hearing Procedures for Certain Transfers of and Declarations of Worthlessness with Respect to Common Stock Filed by Debtor Eiger BioPharmaceuticals, Inc. (Attachments: # 1 Exhibit A), #10 Motion regarding pre or post petition contracts critical vendors. Debtors' Emergency Motion for Entry of an Order (I) Authorizing the Debtors to Pay Certain Prepetition Claims of (A) 503(B)(9) Claimants, (B) Lien Claimants, (C) Critical Vendors, and (D) Foreign Claimants, (II) Confirming Administrative Expense Priority of Outstanding Orders Filed by Debtor Eiger BioPharmaceuticals, Inc. (Attachments: # 1 Exhibit A), #11 Motion to pay tax debts Debtors' Emergency Motion for Entry of Interim and Final Orders Authorizing the Debtors to Pay Certain Taxes and Fees Filed by Debtor Eiger BioPharmaceuticals, Inc. (Attachments: # 1 Exhibit A # 2 Exhibit B # 3 Exhibit C), #12 Motion to establish procedures. Debtors Emergency Motion for Entry of an Order (I) Authorizing the Debtors to (A) File a Consolidated Creditor Matrix and (B) File a Consolidated List of 30 Largest Unsecured Creditors; (II) Waiving the Requirement to File a List of Equity Security Holders; (III) Authorizing the Debtors to Redact Certain Personally Identifying Information; and (IV) Approving the Form and Manner of Notifying Creditors of the Commencement of the Chapter 11 Cases and Other Information Filed by Debtor Eiger BioPharmaceuticals, Inc. (Attachments: # 1 Exhibit A), #13 Motion to establish procedures bid procedures. Debtors Motion for Entry of an Order (I)(A) Approving the Bid Procedures; (B) Authorizing the Debtors to Select Sentynl Therapeutics, Inc. as the Zokinvy Stalking Horse Purchaser & Approving Bid Protections; (C) Approving the Bid Protections Relating to the Remaining Assets Stalking Horse Purchaser(s), if any; (D) Establishing Bid Deadlines, Auction(s), and Sale Hearing(s); (E) Approving the Form and Manner of Sale Notice; (F) Approving Assignment and Assumption Procedures; (G) Approving the Form and Manner of Potential Assumption and Assignment Notice; (II)(A) Authorizing the Sale of the Assets Free and Clear; and (B) Approving the Assumption and Assignment of Designated Contracts; and (III) Granting Related Relief Filed by Debtor Eiger BioPharmaceuticals, Inc. (Attachments: # 1 Exhibit A), #16 Motion to use cash collateral Debtors' Emergency Motion for Entry of Interim and Final Orders (I) Authorizing the Debtors to Use Cash Collateral; (II) Granting Adequate Protection to Prepetition Term Loan Secured Parties; (III) Modifying Automatic Stay; and (IV) Scheduling a Final Hearing Filed by Debtor Eiger BioPharmaceuticals, Inc. (Attachments: # 1 Proposed Interim Order), #17 Motion regarding pre or post petition contracts customers. Debtors Emergency Motion for Entry of Interim and Final Orders (I) Authorizing the Debtors to Honor and Continue Certain Customer Programs and Customer Obligations in the Ordinary Course of Business, and (II) Authorizing Banks to Honor and Process Checks and Electronic Transfer Requests Related Thereto Filed by Debtor Eiger BioPharmaceuticals, Inc. (Attachments: # 1 Exhibit A # 2 Exhibit B), #18 Application to employ Kurtzman Carson Consultants LLC as Claims Agent Debtors' Emergency Application for Entry of an Order Authorizing the Retention and Employment of Kurtzman Carson Consultants LLC as Claims, Noticing, and Solicitation Agent, Effective as of the Petition Date Filed by Debtor Eiger BioPharmaceuticals, Inc. (Attachments: # 1 Exhibit A # 2 Exhibit B # 3 Exhibit C), #19 Declaration re: Declaration of David Apelian in Support of the Chapter 11 Petitions and First Day Pleadings filed by Debtor Eiger BioPharmaceuticals, Inc. (RE: related document(s)#1 Voluntary petition (chapter 11)). (Attachments: # 1 Exhibit A)). (Califano, Thomas) |
| Filing 22 Notice of hearing Notice of Hearing for April 3, 2024 Setting filed by Debtor Eiger BioPharmaceuticals, Inc. (RE: related document(s)#3 Motion for joint administration of cases 24-80040 (SGJ); 24-80041 (SGJ); 24-80042 (SGJ); 24-80043 (SGJ); 24-80044 (SGJ) Debtors Emergency Motion for Entry of an Order Directing Joint Administration of Chapter 11 Cases Filed by Debtor Eiger BioPharmaceuticals, Inc. (Attachments: # 1 Exhibit A), #4 Motion to maintain bank accounts. Debtors Emergency Motion for Entry of Interim and Final Orders (I) Authorizing the Debtors to Continue to Operate Their Cash Management System and Maintain Existing Bank Accounts (II) Honor Certain Obligations Relating Thereto; and (III) Granting a Waiver of Certain Deposit and Investment Requirements in 11 U.S.C. 345(B) and the USTGuidelines Filed by Debtor Eiger BioPharmaceuticals, Inc. (Attachments: # 1 Exhibit A # 2 Exhibit B # 3 Exhibit C # 4 Exhibit D), #5 Motion regarding utilities. Debtors Emergency Motion for Entry of an Order (I) Approving the Debtors Proposed Adequate Assurance of Payment for Future Utility Services, (II) Prohibiting Utility Companies from Altering, Refusing, or Discontinuing Services, and (III) Approving the Debtors Proposed Procedures for Resolving Additional Assurance Requests Filed by Debtor Eiger BioPharmaceuticals, Inc. (Attachments: # 1 Exhibit A # 2 Exhibit B), #6 Motion regarding pre or post petition contracts. Debtors Emergency Motion for Entry of an Order (I) Authorizing the Debtors to (A) Continue Their Prepetition Insurance Coverage and Satisfy Prepetition Obligations Related Thereto and (B) Renew, Supplement, and Enter Into New Insurance Policies, and (II) Granting Related Relief Filed by Debtor Eiger BioPharmaceuticals, Inc. (Attachments: # 1 Exhibit A # 2 Exhibit B), #7 Motion to extend time to Debtors Emergency Motion for Entry of an Order Extending Time to File Schedules of Assets and Liabilities and Statements of Financial Affairs Filed by Debtor Eiger BioPharmaceuticals, Inc. Objections due by 4/3/2024. (Attachments: # 1 Exhibit A), #8 Motion regarding pre or post petition contracts employee wages/benefits. Debtors Emergency Motion for Entry of an Order (I) Authorizing the Debtors to (A) Pay Prepetition Wages, Salaries, and Employee Benefits and (B) Continue the Postpetition Maintenance of Employee Benefit Programs, Policies, and Procedures in the Ordinary Course Filed by Debtor Eiger BioPharmaceuticals, Inc. (Attachments: # 1 Exhibit A), #9 Motion for approval of form notice. Debtors Emergency Motion For Entry of an Order Approving Notification and Hearing Procedures for Certain Transfers of and Declarations of Worthlessness with Respect to Common Stock Filed by Debtor Eiger BioPharmaceuticals, Inc. (Attachments: # 1 Exhibit A), #10 Motion regarding pre or post petition contracts critical vendors. Debtors' Emergency Motion for Entry of an Order (I) Authorizing the Debtors to Pay Certain Prepetition Claims of (A) 503(B)(9) Claimants, (B) Lien Claimants, (C) Critical Vendors, and (D) Foreign Claimants, (II) Confirming Administrative Expense Priority of Outstanding Orders Filed by Debtor Eiger BioPharmaceuticals, Inc. (Attachments: # 1 Exhibit A), #11 Motion to pay tax debts Debtors' Emergency Motion for Entry of Interim and Final Orders Authorizing the Debtors to Pay Certain Taxes and Fees Filed by Debtor Eiger BioPharmaceuticals, Inc. (Attachments: # 1 Exhibit A # 2 Exhibit B # 3 Exhibit C), #12 Motion to establish procedures. Debtors Emergency Motion for Entry of an Order (I) Authorizing the Debtors to (A) File a Consolidated Creditor Matrix and (B) File a Consolidated List of 30 Largest Unsecured Creditors; (II) Waiving the Requirement to File a List of Equity Security Holders; (III) Authorizing the Debtors to Redact Certain Personally Identifying Information; and (IV) Approving the Form and Manner of Notifying Creditors of the Commencement of the Chapter 11 Cases and Other Information Filed by Debtor Eiger BioPharmaceuticals, Inc. (Attachments: # 1 Exhibit A), #13 Motion to establish procedures bid procedures. Debtors Motion for Entry of an Order (I)(A) Approving the Bid Procedures; (B) Authorizing the Debtors to Select Sentynl Therapeutics, Inc. as the Zokinvy Stalking Horse Purchaser & Approving Bid Protections; (C) Approving the Bid Protections Relating to the Remaining Assets Stalking Horse Purchaser(s), if any; (D) Establishing Bid Deadlines, Auction(s), and Sale Hearing(s); (E) Approving the Form and Manner of Sale Notice; (F) Approving Assignment and Assumption Procedures; (G) Approving the Form and Manner of Potential Assumption and Assignment Notice; (II)(A) Authorizing the Sale of the Assets Free and Clear; and (B) Approving the Assumption and Assignment of Designated Contracts; and (III) Granting Related Relief Filed by Debtor Eiger BioPharmaceuticals, Inc. (Attachments: # 1 Exhibit A), #16 Motion to use cash collateral Debtors' Emergency Motion for Entry of Interim and Final Orders (I) Authorizing the Debtors to Use Cash Collateral; (II) Granting Adequate Protection to Prepetition Term Loan Secured Parties; (III) Modifying Automatic Stay; and (IV) Scheduling a Final Hearing Filed by Debtor Eiger BioPharmaceuticals, Inc. (Attachments: # 1 Proposed Interim Order), #17 Motion regarding pre or post petition contracts customers. Debtors Emergency Motion for Entry of Interim and Final Orders (I) Authorizing the Debtors to Honor and Continue Certain Customer Programs and Customer Obligations in the Ordinary Course of Business, and (II) Authorizing Banks to Honor and Process Checks and Electronic Transfer Requests Related Thereto Filed by Debtor Eiger BioPharmaceuticals, Inc. (Attachments: # 1 Exhibit A # 2 Exhibit B), #18 Application to employ Kurtzman Carson Consultants LLC as Claims Agent Debtors' Emergency Application for Entry of an Order Authorizing the Retention and Employment of Kurtzman Carson Consultants LLC as Claims, Noticing, and Solicitation Agent, Effective as of the Petition Date Filed by Debtor Eiger BioPharmaceuticals, Inc. (Attachments: # 1 Exhibit A # 2 Exhibit B # 3 Exhibit C), #21 Notice of designation as complex chapter 11 case Notice of Designation as Complex Chapter 11 Bankruptcy Case filed by Debtor Eiger BioPharmaceuticals, Inc.. (Attachments: # 1 Exhibit A)). Hearing to be held on 4/3/2024 at 01:30 PM Dallas Judge Larson Ctrm for #18 and for #9 and for #8 and for #5 and for #11 and for #4 and for #12 and for #7 and for #3 and for #13 and for #21 and for #6 and for #17 and for #10 and for #16, (Califano, Thomas) |
| Filing 21 Notice of designation as complex chapter 11 case Notice of Designation as Complex Chapter 11 Bankruptcy Case filed by Debtor Eiger BioPharmaceuticals, Inc.. (Attachments: #1 Exhibit A) (Califano, Thomas) |
| Filing 20 Declaration re: Declaration of Paul Rundell, Managing Director of Alvarez & Marsal North America, LLC, in Support of the Debtors Emergency Motion for Entry of Interim and Final Orders (I) Authorizing the Debtors to Use Cash Collateral; (II) Granting Adequate Protection to Prepetition Term Loan Secured Parties; (III) Modifying Automatic Stay; and (IV) Scheduling a Final Hearing filed by Debtor Eiger BioPharmaceuticals, Inc. (RE: related document(s)#16 Motion to use cash collateral Debtors' Emergency Motion for Entry of Interim and Final Orders (I) Authorizing the Debtors to Use Cash Collateral; (II) Granting Adequate Protection to Prepetition Term Loan Secured Parties; (III) Modifying Autom). (Califano, Thomas) |
| Filing 19 Declaration re: Declaration of David Apelian in Support of the Chapter 11 Petitions and First Day Pleadings filed by Debtor Eiger BioPharmaceuticals, Inc. (RE: related document(s)#1 Voluntary petition (chapter 11)). (Attachments: #1 Exhibit A) (Califano, Thomas) |
| Filing 18 Application to employ Kurtzman Carson Consultants LLC as Claims Agent Debtors' Emergency Application for Entry of an Order Authorizing the Retention and Employment of Kurtzman Carson Consultants LLC as Claims, Noticing, and Solicitation Agent, Effective as of the Petition Date Filed by Debtor Eiger BioPharmaceuticals, Inc. (Attachments: #1 Exhibit A #2 Exhibit B #3 Exhibit C) (Califano, Thomas) |
| Filing 17 Motion regarding pre or post petition contracts customers. Debtors Emergency Motion for Entry of Interim and Final Orders (I) Authorizing the Debtors to Honor and Continue Certain Customer Programs and Customer Obligations in the Ordinary Course of Business, and (II) Authorizing Banks to Honor and Process Checks and Electronic Transfer Requests Related Thereto Filed by Debtor Eiger BioPharmaceuticals, Inc. (Attachments: #1 Exhibit A #2 Exhibit B) (Califano, Thomas) |
| Filing 16 Motion to use cash collateral Debtors' Emergency Motion for Entry of Interim and Final Orders (I) Authorizing the Debtors to Use Cash Collateral; (II) Granting Adequate Protection to Prepetition Term Loan Secured Parties; (III) Modifying Automatic Stay; and (IV) Scheduling a Final Hearing Filed by Debtor Eiger BioPharmaceuticals, Inc. (Attachments: #1 Proposed Interim Order) (Califano, Thomas) |
| Filing 15 Notice of deficiency. Schedule A/B due 4/15/2024. Schedule D due 4/15/2024. Schedule E/F due 4/15/2024. Schedule G due 4/15/2024. Schedule H due 4/15/2024. Declaration Under Penalty of Perjury for Non-individual Debtors due 4/15/2024. Summary of Assets and Liabilities and Certain Statistical Information due 4/15/2024. Declaration for electronic filing within 7 days from the filing of the petition. Statement of Financial Affairs due 4/15/2024. Creditor matrix due 4/3/2024. (Hyden, Kara) |
| Filing 14 Notice of Appearance and Request for Notice by Lawrence James Dickinson filed by Interested Party Sentynl Therapeutics, Inc.. (Dickinson, Lawrence) |
| Filing 13 Motion to establish procedures bid procedures. Debtors Motion for Entry of an Order (I)(A) Approving the Bid Procedures; (B) Authorizing the Debtors to Select Sentynl Therapeutics, Inc. as the Zokinvy Stalking Horse Purchaser & Approving Bid Protections; (C) Approving the Bid Protections Relating to the Remaining Assets Stalking Horse Purchaser(s), if any; (D) Establishing Bid Deadlines, Auction(s), and Sale Hearing(s); (E) Approving the Form and Manner of Sale Notice; (F) Approving Assignment and Assumption Procedures; (G) Approving the Form and Manner of Potential Assumption and Assignment Notice; (II)(A) Authorizing the Sale of the Assets Free and Clear; and (B) Approving the Assumption and Assignment of Designated Contracts; and (III) Granting Related Relief Filed by Debtor Eiger BioPharmaceuticals, Inc. (Attachments: #1 Exhibit A) (Califano, Thomas) |
| Filing 12 Motion to establish procedures. Debtors Emergency Motion for Entry of an Order (I) Authorizing the Debtors to (A) File a Consolidated Creditor Matrix and (B) File a Consolidated List of 30 Largest Unsecured Creditors; (II) Waiving the Requirement to File a List of Equity Security Holders; (III) Authorizing the Debtors to Redact Certain Personally Identifying Information; and (IV) Approving the Form and Manner of Notifying Creditors of the Commencement of the Chapter 11 Cases and Other Information Filed by Debtor Eiger BioPharmaceuticals, Inc. (Attachments: #1 Exhibit A) (Califano, Thomas) |
| Filing 11 Motion to pay tax debts Debtors' Emergency Motion for Entry of Interim and Final Orders Authorizing the Debtors to Pay Certain Taxes and Fees Filed by Debtor Eiger BioPharmaceuticals, Inc. (Attachments: #1 Exhibit A #2 Exhibit B #3 Exhibit C) (Califano, Thomas) |
| Filing 10 Motion regarding pre or post petition contracts critical vendors. Debtors' Emergency Motion for Entry of an Order (I) Authorizing the Debtors to Pay Certain Prepetition Claims of (A) 503(B)(9) Claimants, (B) Lien Claimants, (C) Critical Vendors, and (D) Foreign Claimants, (II) Confirming Administrative Expense Priority of Outstanding Orders Filed by Debtor Eiger BioPharmaceuticals, Inc. (Attachments: #1 Exhibit A) (Califano, Thomas) |
| Filing 9 Motion for approval of form notice. Debtors Emergency Motion For Entry of an Order Approving Notification and Hearing Procedures for Certain Transfers of and Declarations of Worthlessness with Respect to Common Stock Filed by Debtor Eiger BioPharmaceuticals, Inc. (Attachments: #1 Exhibit A) (Califano, Thomas) |
| Filing 8 Motion regarding pre or post petition contracts employee wages/benefits. Debtors Emergency Motion for Entry of an Order (I) Authorizing the Debtors to (A) Pay Prepetition Wages, Salaries, and Employee Benefits and (B) Continue the Postpetition Maintenance of Employee Benefit Programs, Policies, and Procedures in the Ordinary Course Filed by Debtor Eiger BioPharmaceuticals, Inc. (Attachments: #1 Exhibit A) (Califano, Thomas) |
| Filing 7 Motion to extend time to Debtors Emergency Motion for Entry of an Order Extending Time to File Schedules of Assets and Liabilities and Statements of Financial Affairs Filed by Debtor Eiger BioPharmaceuticals, Inc. Objections due by 4/3/2024. (Attachments: #1 Exhibit A) (Califano, Thomas) |
| Filing 6 Motion regarding pre or post petition contracts. Debtors Emergency Motion for Entry of an Order (I) Authorizing the Debtors to (A) Continue Their Prepetition Insurance Coverage and Satisfy Prepetition Obligations Related Thereto and (B) Renew, Supplement, and Enter Into New Insurance Policies, and (II) Granting Related Relief Filed by Debtor Eiger BioPharmaceuticals, Inc. (Attachments: #1 Exhibit A #2 Exhibit B) (Califano, Thomas) |
| Filing 5 Motion regarding utilities. Debtors Emergency Motion for Entry of an Order (I) Approving the Debtors Proposed Adequate Assurance of Payment for Future Utility Services, (II) Prohibiting Utility Companies from Altering, Refusing, or Discontinuing Services, and (III) Approving the Debtors Proposed Procedures for Resolving Additional Assurance Requests Filed by Debtor Eiger BioPharmaceuticals, Inc. (Attachments: #1 Exhibit A #2 Exhibit B) (Califano, Thomas) |
| Filing 4 Motion to maintain bank accounts. Debtors Emergency Motion for Entry of Interim and Final Orders (I) Authorizing the Debtors to Continue to Operate Their Cash Management System and Maintain Existing Bank Accounts (II) Honor Certain Obligations Relating Thereto; and (III) Granting a Waiver of Certain Deposit and Investment Requirements in 11 U.S.C. 345(B) and the USTGuidelines Filed by Debtor Eiger BioPharmaceuticals, Inc. (Attachments: #1 Exhibit A #2 Exhibit B #3 Exhibit C #4 Exhibit D) (Califano, Thomas) |
| Filing 3 Motion for joint administration of cases 24-80040 (SGJ); 24-80041 (SGJ); 24-80042 (SGJ); 24-80043 (SGJ); 24-80044 (SGJ) Debtors Emergency Motion for Entry of an Order Directing Joint Administration of Chapter 11 Cases Filed by Debtor Eiger BioPharmaceuticals, Inc. (Attachments: #1 Exhibit A) (Califano, Thomas) |
| Filing 2 Notice of Appearance and Request for Notice for Innovatus Life Sciences Lending Fund I, LP by Jay Robert Bender Filed by Creditor INNOVATUS LIFE SCIENCES LENDING FUND I, LP. (Bender, Jay) |
| Filing 1 Non-individual Chapter 11 Voluntary Petition. Fee Amount $1738 Filed by Eiger BioPharmaceuticals, Inc. Chapter 11 Plan due by 07/30/2024. Disclosure Statement due by 07/30/2024. (Califano, Thomas) |
| Receipt of filing fee for Voluntary petition (chapter 11)(# 24-80040-11) [misc,volp11a] (1738.00). Receipt number A31284451, amount $1738.00 (re: Doc#1). (U.S. Treasury) |
| Search for this case: Eiger BioPharmaceuticals, Inc. | |
|---|---|
| Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
| Search Web | [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ] |
| Debtor: Eiger BioPharmaceuticals, Inc. | |
| Represented By: | Thomas Robert Califano |
| Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
| Search Finance | [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ] |
| Search Web | [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ] |
| Us trustee: United States Trustee | |
| Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
| Search Finance | [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ] |
| Search Web | [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ] |
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
